Multicenter, Prospective, Randomized, Controlled, Double-blind Trial on the Impact of Rosuvastatin on Subclinical Markers of Atherosclerosis in Patients With Primary Necrotizing Vasculitides
Clinical trial NCT02117453 · COMPLETED
Trial details
- NCT number
- NCT02117453
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-27
- Primary completion
- 2019-11-07
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.